Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-20

Clinical Trial Update: The Use of Oracea and Epiduo Forte in Severe Acne Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the use of Oracea and Epiduo Forte in severe acne patients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPIDUO FORTE (adapalene and benzoyl peroxide)
  • ORACEA (Doxycycline)

Snippet

Sponsor: Derm Research, PLLC | Conditions: Acne | Phase 4 | Status: COMPLETED | Results posted: 2019-03-20